	BASF will build a new specialty amines plant at its existing wholly owned site in Nanjing Chemical Industry Park in China, the company announced in a Sept. 25, 2017 press release. The new multi-product plant can manufacture 21,000 metric tons per year and further extends BASF’s amines portfolio at the specialty amines complex in Nanjing.  The plant is scheduled to come on stream in 2019 and will mainly produce 1,2-Propylenediamine (1,2-PDA), n-Octylamine (n-OA), and Polyetheramine (PEA). 1,2-PDA is a building block in the manufacture of pharmaceuticals as well as other chemicals.

	“This investment will help us to meet the increasing Asia Pacific demand for specialty amines used as intermediates in a diverse range of industries …,” said Narayan Krishnamohan, senior vice-president, Intermediates Asia Pacific, BASF, in the press release. “Through this expansion, we will be able to better serve our customers in Asia Pacific with steady and timely supply of quality products.”

	BASF also has manufacturing capacities for both 1,2-PDA and n-OA at its Ludwigshafen Verbund site in Germany. 

API Synthesis and Manufacturing, Small Molecule

Development

Ingredients

PharmTech News

Small-Molecule APIs

Supplier News

PTSM: Pharmaceutical Technology Sourcing and Management-10-04-2017

BASF will build a new specialty amines plant at its existing wholly owned site in Nanjing Chemical Industry Park in China.